To further determine the dependence of the USP10 function on SKP2 status, we next examined the activation of Bcr-Abl in CML cells stably expressing control shRNA or shUSP10 with or without HA-SKP2 plasmids. The gene discussed is SKP2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.